Table 3.
Outcome measurement instrument | Studies in the domain, N | Absolute frequency (n) and share in the domain, n (%) | Share in all studies (N=303), n (%) | |||||
PROMa | ||||||||
|
HRQoLb | |||||||
|
|
EuroQol five-dimension scale | 307 | 44 (14.3) | 44 (14.5) | |||
|
|
Short Form 36 | 307 | 36 (11.7) | 36 (11.9) | |||
|
|
Short Form 12 | 307 | 19 (6.2) | 19 (6.3) | |||
|
Physical function | |||||||
|
|
International Physical Activity Questionnaire | 57 | 7 (12.3) | 7 (0.2) | |||
|
|
Nottingham Extended Activities of Daily Living Scale | 57 | 4 (7) | 4 (1.3) | |||
|
|
Active Australia Survey, Activities-specific Balance Scale, and Physical Activity Scale for the Elderly | 57 | 3 (5.2) | 3 (1) | |||
|
Social function | |||||||
|
|
Work Productivity and Activity Impairment Questionnaire | 9 | 2 (22.2) | 2 (0.7) | |||
|
|
CHAMPS Activities Questionnaire for Older Adults, World Health Organization Health and Work Performance Questionnaire, Social Phobia Screening Questionnaire, and others | 9 | 1 (11.1) | 1 (0.3) | |||
|
Emotional function | |||||||
|
|
Patient Health Questionnaire-9 | 244 | 27 (11.1) | 27 (8.9) | |||
|
|
Hospital Anxiety and Depression Scale | 244 | 23 (9.4) | 23 (7.6) | |||
|
|
Center for Epidemiologic Studies Depression Scale | 244 | 16 (6.6) | 16 (5.3) | |||
|
Cognitive function | |||||||
|
|
Brief Illness Perception Questionnaire | 41 | 3 (7.3) | 3 (1) | |||
|
|
Supportive Care Needs Survey Short Form 34, Supportive Care Needs Survey Screening Tool 9, and Illness Perception Questionnaire | 41 | 2 (4.9) | 2 (0.7) | |||
|
|
Body Attitude Test, Functional Activities Questionnaire, Illness Cognition Questionnaire, and others | 41 | 1 (2.4) | 1 (0.3) | |||
|
Health literacy | |||||||
|
|
European Heart Failure Self-Care Behaviour Scale and Self-Care of Heart Failure Index | 35 | 3 (8.6) | 3 (1) | |||
|
|
Health Education Impact Questionnaire, Health Promoting Lifestyle Profile II, Patient Enablement Instrument, and others | 35 | 2 (5.7) | 2 (0.7) | |||
|
|
Cancer Empowerment Questionnaire, Diabetes Self-Management Profile, Revised Heart Failure Compliance, and others | 35 | 1 (2.9) | 1 (0.3) | |||
|
Side effects | |||||||
|
|
Patient Neurotoxicity Questionnaire, Glasgow Antipsychotic Side-Effect Scale, Side Effects of Anti-epileptic Drugs, and others | 8 | 1 (12.5) | 1 (0.3) | |||
|
Adherence | |||||||
|
|
Morisky Medication Adherence Scale | 103 | 5 (4.9) | 5 (1.7) | |||
|
|
Medication Adherence Rating Scale | 103 | 4 (3.9) | 4 (1.3) | |||
|
|
AIDS Clinical Trails Group Adherence Questionnaire | 103 | 1 (1) | 1 (0.3) | |||
PREMc | ||||||||
|
Treatment | |||||||
|
|
Client Satisfaction Questionnaire | 29 | 12 (41.4) | 12 (4) | |||
|
|
Diabetes Treatment Satisfaction Questionnaire, Patient Assessment of Chronic Illness Care, and Patient Satisfaction Questionnaire Short Form | 29 | 2 (6.9) | (0.7) | |||
|
|
Canadian Health Care Evaluation Project questionnaire, Patient Experience Questionnaire, Functional Assessment of Chronic Illness Therapy–Treatment Satisfaction–Patient Satisfaction, and others | 29 | 1 (3.4) | 1 (0.3) | |||
|
Technology | |||||||
|
|
System Usability Scale | 22 | 6 (27.3) | 6 (2) | |||
|
|
Telehealth Acceptance Measure | 22 | 3 (13.6) | 3 (1) | |||
|
|
Post-Study System Usability Questionnaire and Usefulness, Satisfaction, and Ease of use Questionnaire | 22 | 2 (12.3) | 2 (0.7) |
aPROM: patient-reported outcome measure.
bHRQoL: health-related quality of life.
cPREM: patient-reported experience measure.